ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CLDX Celldex Therapeutics Inc

37.77
0.00 (0.00%)
Pre Market
Last Updated: 07:53:06
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Celldex Therapeutics Inc CLDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 37.77 07:53:06
Open Price Low Price High Price Close Price Prev Close
37.77
more quote information »

Recent News

Date Time Source Heading
4/17/202408:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
3/08/202407:00GLOBECelldex Therapeutics to Participate in the Leerink Partners..
3/05/202410:30GLOBECelldex Therapeutics to Present at TD Cowen’s 44th Annual..
3/05/202410:10GLOBECelldex Therapeutics Announces Closing of Public Offering of..
3/01/202416:10EDGAR2Form 8-K - Current report
3/01/202416:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202421:14GLOBECelldex Therapeutics Announces Pricing of Upsized $400..
2/28/202416:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/28/202416:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
2/26/202408:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/26/202407:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/26/202407:01EDGAR2Form 8-K - Current report
2/26/202407:01GLOBECelldex Reports Fourth Quarter and Year End 2023 Financial..
2/24/202414:05GLOBECelldex Therapeutics Presents Positive 12 Week Results from..
2/15/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202416:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202412:52EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202411:48EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202407:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202409:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/08/202410:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202416:01GLOBECelldex to Participate in the Guggenheim Healthcare Talks..
2/05/202408:01GLOBECelldex Announces Upcoming Presentation of Barzolvolimab..
1/04/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/27/202316:15GLOBECelldex Therapeutics to Present at 6th Annual Evercore ISI..
11/20/202316:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/08/202317:03EDGAR2Form 8-K - Current report
11/08/202317:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/07/202323:15GLOBECelldex Therapeutics Announces Pricing of Public Offering of..
11/07/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/07/202316:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
11/06/202309:00EDGAR2Form 8-K - Current report
11/06/202306:30GLOBECelldex Therapeutics Announces Positive Topline Results from..
11/05/202315:00GLOBECelldex Therapeutics Presents Positive Data from Prurigo..
11/03/202316:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/02/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202316:01EDGAR2Form 8-K - Current report
11/02/202316:01GLOBECelldex Reports Third Quarter 2023 Financial Results and..
9/26/202307:01GLOBECelldex Announces Acceptance of Abstract for Barzolvolimab..
9/25/202308:31GLOBECelldex Therapeutics to Present at Cantor Global Healthcare..
8/08/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:01EDGAR2Form 8-K - Current report
8/08/202316:01GLOBECelldex Reports Second Quarter 2023 Financial Results and..
7/11/202308:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
7/06/202308:01GLOBECelldex Announces First Patient Dosed in Phase 2 Study of..
6/10/202310:45GLOBECelldex Therapeutics Presents Positive Data from..
6/08/202316:01GLOBECelldex Therapeutics Announces Upcoming Barzolvolimab..
6/02/202308:01GLOBECelldex Therapeutics to Present at Jefferies Healthcare..
5/31/202308:01GLOBECelldex Announces First Patient Dosed in Phase 1 Study of..
5/15/202308:01GLOBECelldex Therapeutics Presents Positive Preclinical Data from..

Your Recent History

Delayed Upgrade Clock